Valerie Grignol, MDThe James Cancer Center
- Breast Cancer
- Clinical Trials as Topic
- Surgical Oncology
Make an Appointment
I’m a surgical oncologist who treats patients suffering from breast cancer and sarcoma. Although my specialty is surgery, I consider myself a cancer doctor first and foremost. There are many ways to treat cancer and it’s important to consider all of them. I also serve as an assistant professor of surgery at the Wexner Medical Center.
The multidisciplinary approach to cancer care at OSUCCC – James is evidenced by presence of tumor boards. These review boards ensure that each patient’s tumor receives evaluation by experts across cancer specialties. It’s a highly effective way to help customize treatment.
I’ve been the co-author of more than 16 journal articles in publications including Surgical Oncology, Journal of the American College of Surgeons and the Journal of Immunology. I’ve presented my work at more than 20 national, regional and local meetings, and I participate in a number of clinical trials.
Like everyone at The James, I’m inspired and driven by the opportunity to provide the best possible treatment and improve our patients’ lives and outcomes.
Education and Background
Wright State University Boonshoft School of Medicine
Ohio State University Wexner Medical Center
- American Board of Surgery
- Department of Surgery
- Division of Surgical Oncology
I see patients at
Stefanie Spielman Comprehensive Breast Center
1145 Olentangy River Road, Columbus, Ohio 43212
The James Cancer Hospital and Solove Research Institute
460 West 10th Avenue, Columbus, Ohio 43210
Consulting and Related Relationships
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 3/28/2017, Dr. Grignol has reported no financial relationships with medical device, research and/or drug companies.